CORONA Remedies Acquires Wokadine® from Dr. Reddy’s in India

CORONA Remedies Limited has announced the acquisition of Wokadine® from Dr. Reddy’s Laboratories Ltd. This strategic acquisition marks CORONA’s fifth acquisition and reinforces its commitment to ‘Healing’. The acquisition will enable CORONA to penetrate deeper into targeted specialty and offer wider accessibility. The brand holds strong potential for accelerated growth under CORONA Remedies’ stewardship. The acquisition will be fully funded through the company’s internal accruals and cash.